Net Sales Margin: calidibio.com (CLDI)

Brandmark of Calidi Biotherapeutics (CLDI)

High binary risks and dependence on external financing are putting pressure on Calidi Biotherapeutics (CLDI). However, the use of stem cells for targeted viral delivery into tumors and the outsourcing of clinical trials are reducing capital expenditures. The net profit margin demonstrates a support level, where the value 0.00 denotes the current indicator of profit management efficiency relative to revenue.

Calidi Biotherapeutics Inc. (CLDI) - Company Sales Margin from 02/21/2024 to 11/19/2026

Financial and market metric breakdowns for calidibio.com (CLDI)

- company stock exchange capitalization indicators:
Analysis of all company metrics:Calidi Biotherapeutics
Flagship merchandise of Calidi Biotherapeutics

Investors are verifying the financial stability of Calidi Biotherapeutics (CLDI) through a system of profitability multiples. This net profit margin reflects the portion of final income in every dollar of revenue after deducting all expenses. The negative trend of this indicator is typical for Calidi Biotherapeutics, as the company focuses on clinical trials of oncolytic viruses. Current development costs exceed revenues from production alliances. Analyzing this metric allows for an assessment of the capital burn rate.

Analysis of competing companies

ONC: Net Sales Margin|Net Margin Halozyme Inc. (HALO)|Net Margin RevMed|Net Return on Sales AAPG (Ascentage Pharma Group)|Net Sales Margin CGON|UroGen Pharma - Net Return on Sales|Bicara Therapeutics - Return on Sales by Net Profit|Net Sales Margin Personalis Inc PSNL|Erasca Oncology - Net Sales Margin|Net Profit Rate DCTH (Delcath Corp)|YMAB: Net Sales Margin|AURA - Company Sales Margin|CADL (Candel Therapeutics Inc.) - Net Sales Margin|Net Return on Sales ARAY (Accuray)|Return on Sales by Net Profit SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Net Margin|Net Margin Citius Oncology, Inc. CTOR|HURA - Return on Sales by Net Profit|protaratx.com - Net Sales Margin|FATE - Net Sales Margin|WHWK: Net Sales Margin|TScan Therapeutics (TCRX) - Net Sales Margin|Net Margin Champions Oncology|Net Margin XBIT|Net Sales Margin CVM|Return on Sales by Net Profit OS Therapies Inc. OSTX|Net Margin Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Net Margin|ANL - Net Margin|Net Margin verupharma.com|TPST: Net Sales Margin|XLO - Company Sales Margin|Net Margin Renovaro|Net Sales Margin muraloncology.com|Net Sales Margin KAPA|Company Sales Margin OnKure Therapeutics, Inc.|Net Sales Margin GDTC (w2.cytomed.sg)|CRIS - Return on Sales by Net Profit|Apollomics - Net Sales Margin|Tharimmune Corp (THAR) - Return on Sales by Net Profit|ADVB: Net Sales Margin|Return on Sales by Net Profit Genprex|Net Margin Sunshine Biopharma, Inc.|Net Sales Margin xeneticbio.com|Net Margin Salarius (SLRX)|Return on Sales by Net Profit Purple Biotech PPBT|Net Margin American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Net Margin|Checkpoint Therapeutics Inc. - Net Sales Margin|Net Profit Rate ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Return on Sales by Net Profit|Ikena Oncology, Inc. - Net Profit Rate|Return on Sales by Net Profit NTBL|VIRX: Net Profit Rate|Net Margin MorphoSys Corporation (MOR)|NAYA - Net Margin|Net Sales Margin AAPGV (Ascentage)